TANSEY MICHAEL JAMES BYRON 4/A
4/A · LA JOLLA PHARMACEUTICAL CO · Filed Feb 3, 2009
Insider Transaction Report
Form 4/AAmended
TANSEY MICHAEL JAMES BYRON
Executive VP & CMO
Transactions
- Award
Stock Option (right to buy)
2009-01-22+45,000→ 45,000 totalExercise: $1.42Exp: 2019-01-22→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock options vest and become exercisable monthly over the next four years.